Literature DB >> 20110705

Ileocolonic involvement in Behçet's disease: endoscopic and histological evaluation.

Seyfettin Köklü1, Osman Yüksel, Ilknur Onur, Selman Unverdi, Ibrahim Biyikoğlu, Erdem Akbal, Demet Sengül, Hatice Unverdi, Meral Ekşioğlu.   

Abstract

BACKGROUND: Our aim was to document the frequency of gastrointestinal (GI) involvement of Behçet's disease (BD) at endoscopic examination. Also, we aimed to analyze whether GI lesions were correlated with other systemic components of BD.
METHODS: Fifty patients with BD were enrolled in the study. Patients in whom optimal colonoscopic examination of both the colon and terminal ileum could be performed were included. An ileum biopsy was taken from all cases. Upper GI endoscopy findings, presence of genital ulcers, uveitis, dermatological lesions, pathergy test, neurological involvement and peripheral vasculitis, and laboratory findings were recorded. Thirty age- and sex-matched persons who had perfect bowel cleansing and had a macroscopically normal colon and terminal ileum at colonoscopy without any systemic diseases were enrolled as the control group.
RESULTS: Nine patients and 1 case had macroscopic ileum and colon lesions, respectively. Microscopic examination of BD patients with normal colon and terminal ileum at colonoscopy revealed 61% abnormal ileum histologies. That ratio was 30% for the control group (p < 0.001). None of the patients had any lesions suggesting BD at upper GI endoscopy. There was no correlation between macro- or microscopic GI involvement and other components of BD.
CONCLUSIONS: Lower GI tract, especially ileum involvement, is frequent in BD. Most of the patients have inflammation in the ileum even in the absence of macroscopic lesions.

Entities:  

Mesh:

Year:  2010        PMID: 20110705     DOI: 10.1159/000264643

Source DB:  PubMed          Journal:  Digestion        ISSN: 0012-2823            Impact factor:   3.216


  9 in total

Review 1.  Adamantiades-Behcet's disease-complicated gastroenteropathy.

Authors:  Qing-Jun Wu; Feng-Chun Zhang; Xuan Zhang
Journal:  World J Gastroenterol       Date:  2012-02-21       Impact factor: 5.742

2.  Mimicry and deception in inflammatory bowel disease and intestinal behçet disease.

Authors:  Erika L Grigg; Sunanda Kane; Seymour Katz
Journal:  Gastroenterol Hepatol (N Y)       Date:  2012-02

Review 3.  Behcet's Syndrome.

Authors:  Sam R Dalvi; Resit Yildirim; Yusuf Yazici
Journal:  Drugs       Date:  2012-12-03       Impact factor: 9.546

4.  Pathologic Features of Behçet's Disease in the Tubuler Gut.

Authors:  Tuba Kara; Duygu Düşmez Apa
Journal:  Patholog Res Int       Date:  2011-11-15

5.  Colon perforation and Budd-Chiari syndrome in Behçet's disease.

Authors:  Yılmaz Baş; Güven Güney; Pınar Uzbay; Ethem Zobacı; Selin Ardalı; Ayşegül Taylan Özkan
Journal:  Am J Case Rep       Date:  2015-05-02

6.  The Role of Fecal Calprotectin in Evaluating Intestinal Involvement of Behçet's Disease.

Authors:  Burak Özşeker; Cem Şahin; Havva Solak Özşeker; S Cumali Efe; Taylan Kav; Yusuf Bayraktar
Journal:  Dis Markers       Date:  2016-08-24       Impact factor: 3.434

7.  C-reactive protein is associated with postoperative outcomes in patients with intestinal Behçet's disease.

Authors:  Eun Ae Kang; Jung Won Park; Min Soo Cho; Jae Hee Cheon; Yehyun Park; Soo Jung Park; Tae Il Kim; Won Ho Kim
Journal:  BMC Gastroenterol       Date:  2021-10-07       Impact factor: 3.067

8.  Case report: laparoscopic radical cystectomy on a patient with Behçet's syndrome, our initial experience on perioperative safety.

Authors:  Xiaoqiang Xue; Xinyi Yang; Zhigang Ji; Yi Xie
Journal:  Transl Androl Urol       Date:  2022-02

9.  Evidence-based diagnosis and clinical practice guidelines for intestinal Behçet's disease 2020 edited by Intractable Diseases, the Health and Labour Sciences Research Grants.

Authors:  Kenji Watanabe; Satoshi Tanida; Nagamu Inoue; Reiko Kunisaki; Kiyonori Kobayashi; Masakazu Nagahori; Katsuhiro Arai; Motoi Uchino; Kazutaka Koganei; Taku Kobayashi; Mitsuhiro Takeno; Fumiaki Ueno; Takayuki Matsumoto; Nobuhisa Mizuki; Yasuo Suzuki; Tadakazu Hisamatsu
Journal:  J Gastroenterol       Date:  2020-05-07       Impact factor: 7.527

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.